Sign in / Join Now
ETFs & Funds
Civitas secured yesterday $55 million for phase III on a competing product, inhaler rescue therapy with with levodopa. $
Add a reply...
Latest StockTalks »
people get CYNA breaking news and analysis by email alert.
Get email alerts on CYNA »
Get latest price
From other sites
Cynapsus Therapeutics Obtains Final Court Order And HSR Waiting Period Expires For Plan Of Arrangement With Sunovion Pharmaceuticals
at TheStreet (Oct 18, 2016)
Cynapsus Therapeutics Securityholders Approve The Plan Of Arrangement With Sunovion Pharmaceuticals
at TheStreet (Oct 13, 2016)
ISS Recommends Cynapsus Therapeutics Securityholders Vote For The Plan Of Arrangement
at TheStreet (Sep 28, 2016)
Cynapsus Therapeutics Inc. Acquisition May Not Be In The Best Interests Of CYNA Shareholders
at TheStreet (Sep 8, 2016)
CYNAPSUS SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces The Investigation Of Cynapsus Therapeutics Inc. (CYNA) Over The Proposed Sale Of The Company To Sunovion Pharmaceuticals Inc.
at TheStreet (Sep 6, 2016)